Natasha Niebieskikwiat
02/17/2021 1:12 PM
Clarín.com
Society
Updated 02/17/2021 1:12 PM
The government started talks in Israel confirming its clear interest in the vaccine that is being researched there and is still under development.
The Argentine sources consulted also indicated that they
seek to position themselves
in the event that the Israeli drug reaches a state of successful acceptance, approval and readiness for its commercialization and export.
Beyond the global problems that exist in the face of the eagerness in all countries to acquire the drug against the pandemic and the shortage of it by the pharmaceutical industry,
Argentina is lagging behind
when the ambitious plans announced and the materialization are compared thereof.
The truth is that the
international executive director
l
Hadassah Hospital in Jerusalem, Jorge Diener,
received Ambassador
Sergio Urribarri
to which explained the status of the development of the vaccine whose research is in the
hands actually the Institute Biological Israel.
To sign any type of agreement weeks or even months are missing, they warn.
They even talked about future cooperation with it.
Israel has been the leader in world vaccination, but it
opted for the Pfizer / BioNTech
(American-German)
vaccine
and with it it vaccinated at the moment about 5 million people and -
45 percent of its population
- of which 2.6 million have already received the second dose according to official information.
Even so, Israelis, who have one of the highest scientific developments in the world, consider the development of their own vaccine to be central, taking into account the
high level of demand
that is needed to reduce the attack of the virus: two doses every six months per person.
Ambassador Sergio Urribarri with the executive director of the Hadassah Hospital in Jerusalem, Jorge Diener.
Urribarri and other members of the Argentine Foreign Ministry made this tour through Hadassah, which already has agreements with Argentine establishments such as the children's hospital, Garrahan and others, and is currently one of the Israeli centers that already has cooperation agreements with the Institute Biological researching the COVID vaccine for months.
"The Israeli vaccine is still in Phase II, it
is premature to talk about its arrival in Argentina
. It still needs to pass Phase III and pass both the domestic and international approval process. We do not rule out the possibility that they may reach Argentina after all the process that lies ahead, but we emphasize that it is still early, "said Israeli diplomatic sources after consulting this newspaper.
For his part, Diener, who is of Argentine origin, said that 180 volunteers participated in Phase II and
20,000 volunteers
participated in Phase II
.
Hadassah is a private but not-for-profit hospital and serves the entire population.
As it also does research, and is an important center for supplying pharmacological drugs to patients -1.5 million a year- it
cared for a significant part of the population infected with coronavirus
.
Regarding this vaccine in development, it is already in talks with other countries in the region, such as Brazil and Mexico.
$
Look also
Back to classes in the City: they added groups and there was more circulation on streets and highways
Axel Kicillof confirmed that they will vaccinate against the coronavirus to references from different areas to generate confidence: "They sowed fear"